Picture of Babylon Holdings logo

BBLNF Babylon Holdings Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for Babylon Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
R2020
December 31st
R2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K
Standards:
IFRS
USG
USG
USG
Status:FinalFinalFinalFinal
Revenue
Total Revenue1679.33211,110
Cost of Revenue
Gross Profit-3.78
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1792806301,479
Operating Profit-163-201-309-370
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-146-208-84.9-222
Provision for Income Taxes
Net Income After Taxes-140-213-83.4-221
Minority Interest
Net Income Before Extraordinary Items
Net Income-140-212-77.4-221
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-140-212-77.4-221
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-7.95-12-4.83-9.75
Dividends per Share